Skip to main content

Clostridium difficile Toxinotyping

  • Protocol
Clostridium difficile

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 646))

Abstract

Clostridium difficile shows considerable variability in the PaLoc region encoding two main virulence factors, toxins TcdA and TcdB. Strains with changes in PaLoc are defined as variant toxinotypes and currently 27 such groups are recognized (I to XXVII). Toxinotype 0 includes strains with PaLoc identical to the reference laboratory strain VPI 10463. Toxinotyping is a RFLP-PCR-based method using a combination of restriction patterns of part of tcdB and tcdA genes for determination of toxinotype. Variations in PaLoc can affect the toxin production or could result in production of toxins with altered properties.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Braun V, Hundesberger T, Leukel P, Sauerborn M and von Eichel–Streiber C. (1996) Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 181, 29–38.

    Article  PubMed  CAS  Google Scholar 

  2. Rupnik M, Dupuy B, Fairweather NF, Gerding DN, Johnson S, Just I, Lyerly DM, Popoff MR, Rood JI, Sonenshein AL, Thelestam M, Wren BW, Wilkins TD and Eichel-Streiber CV. (2005) Revised nomenclature of Clostridium difficile toxins and associated genes. J Med Microbiol 54, 113–117.

    Article  PubMed  CAS  Google Scholar 

  3. Borriello SP, Wren BW, Hyde S, Seddon SV, Sibbons P, Krishna MM, Tabaqchali S, Manek S and Price AB. (1992) Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun 60, 4192–4199.

    PubMed  CAS  Google Scholar 

  4. Lyerly DM, Barroso LA, Wilkins TD, Depitre C and Corthier G. (1992) Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun 60, 4633–4639.

    PubMed  CAS  Google Scholar 

  5. Depitre C, Delmée M, Avesani V, L’Haridon R, Roels A, Popoff M and Corthier G. (1993) Serogroup F strains of Clostridium difficile produce toxin B but not toxin A. J Med Microbiol 38, 434–441.

    Article  PubMed  CAS  Google Scholar 

  6. Rupnik M, Avesani V, Janc M, von Eichel–Streiber C and Delmée M. (1998) A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36, 2240–2247.

    PubMed  CAS  Google Scholar 

  7. Rupnik M. (2008) Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev 32, 541–555.

    Article  PubMed  CAS  Google Scholar 

  8. Spigaglia P and Mastrantonio P. (2002) Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40, 3470–3475.

    Article  PubMed  CAS  Google Scholar 

  9. Curry SR, Marsh JW, Muto CA, O’Leary MM, Pasculle AW and Harrison LH. (2007) tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol 45, 215–221.

    Article  PubMed  CAS  Google Scholar 

  10. Chaves-Olarte E, Freer E, Parra A, Guzman-Verri C, Moreno E and Thelestam M. (2003) R-Ras glucosylation and transient RhoA activation determine the cytopathic effect produced by toxin B variants from toxin A-negative strains of Clostridium difficile. J Biol Chem 278, 7956–7963.

    Article  PubMed  CAS  Google Scholar 

  11. Perelle S, Gibert M, Bourlioux P, Corthier G and Popoff MR. (1997) Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun 65, 1402–1407.

    PubMed  CAS  Google Scholar 

  12. Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B and Popoff M. (2000) Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 186, 307–312.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grant J3-0194-0377-08.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Rupnik, M. (2010). Clostridium difficile Toxinotyping. In: Mullany, P., Roberts, A.P. (eds) Clostridium difficile. Methods in Molecular Biology™, vol 646. Humana Press. https://doi.org/10.1007/978-1-60327-365-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-365-7_5

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-364-0

  • Online ISBN: 978-1-60327-365-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics